Related Experiment Videos

Protective effects of diallyl sulfide on N-nitrosodimethylamine-induced immunosuppression in mice

H G Jeong1, Y W Lee

  • 1Department of Biological Science, Chosun University, Kwangju, South Korea. hgjeong@chosun.ac.kr

Cancer Letters
|June 25, 1999
PubMed

Insights

Diallyl sulfide (DAS) protects against N-nitrosodimethylamine (NDMA)-induced immune suppression in mice. DAS inhibits NDMA bioactivation by blocking cytochrome P450 2E1 activity, preserving immune responses.

Area of Science:

  • Toxicology
  • Immunology
  • Natural Products Chemistry

Background:

  • Diallyl sulfide (DAS), a garlic component, shows chemopreventive effects.
  • Chemical carcinogens like N-nitrosodimethylamine (NDMA) can suppress immune function.
  • Cytochrome P450 enzymes mediate carcinogen activation and metabolism.

Purpose of the Study:

  • To investigate the protective effect of DAS against NDMA-induced immunosuppression.
  • To elucidate the mechanisms underlying DAS protection, focusing on cytochrome P450 2E1.

Main Methods:

  • BALB/c mice were orally administered DAS prior to NDMA treatment for 14 days.
  • Humoral immunity was assessed by antibody response to sheep erythrocytes.
  • Cellular immunity was evaluated by lymphoproliferative responses to mitogens.
  • Cytochrome P450 2E1 activity was measured using p-nitrophenol hydroxylase and NDMA demethylase assays.

Main Results:

  • DAS administration blocked NDMA-induced suppression of antibody and lymphoproliferative responses in a dose-dependent manner.
  • DAS treatment significantly decreased cytochrome P450 2E1-dependent enzyme activities.
  • Inhibition of NDMA bioactivation by DAS was observed.

Conclusions:

  • Diallyl sulfide protects against NDMA-induced immunotoxicity.
  • The protective effect is partly attributed to DAS inhibiting cytochrome P450 2E1, thereby blocking NDMA bioactivation.

Related Concept Videos